Financial Times - Oct 2
Oct 2 (Reuters) -The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.
Headlines
Starmer looks for post-Brexit 'reset' in meeting with EU leaders
Barclays details plans to revamp investment banking returns
EU policymakers lash out at Berlin's Commerzbank 'hypocrisy'
Charles Schwab Chief Walt Bettinger to retire at end of year
Eli Lilly considers testing weight-loss drugs on people who are not overweight
Overview
Keir Starmer will take his mission to "reset" Britain's relations with the EU to Brussels on Wednesday, but European capitals are warning that the UK Prime Minister should not expect an easy ride.
Barclays BARC.L has set out a plan to improve returns within its investment bank by focusing on advisory and equity capital markets work while becoming less reliant on debt underwriting.
Senior European policymakers and economists have sharply criticised the German government over its opposition to a takeover of Commerzbank CBKG.DE by Italian rival UniCreditCRDI.MI, arguing its protectionist approach ran counter to fundamental EU principles.
Charles Schwab's SCHW.N longtime chief executive Walt Bettinger will retire at the end of the year and be replaced by the company's president Rick Wurster.
Eli Lilly is considering testing its blockbuster weight-loss drugs in people who are not overweight, but are at risk of weight gain, in an early sign that the drugmaker may look to broaden the rollout of the medications beyond obese patients.
(Compiled by Bengaluru newsroom)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
